12-O-tetradecanoylphorbol-13-acetate inhibits aminophospholipid translocase activity and modifies the lateral motions of fluorescent phospholipid analogs in the plasma membrane of bovine aortic endothelial cells.

The tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) is a potent mitogenic factor which can replace the growth promoting activity of basic fibroblast growth factor (bFGF) on bovine aortic endothelial cells. However, TPA-treated cells lose their strict contact inhibition at confluence, which is a characteristic of cells grown in the presence of bFGF. We have examined whether these changes could be related to modifications of the transbilayer and lateral motions of fluorescent lipids, namely 1-acyl-2-[6-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]caproyl]-p hosphatidylcholine (C6-NBD-PC), -phosphatidylserine (C6-NBD-PS), and -phosphatidylethanolamine (C6-NBD-PE) inserted in the outer leaflet of the cell plasma membrane. In TPA-treated cells, the three fluorescent phospholipids remained located in the outer leaflet for at least 1 h at 20 degrees C after their insertion, indicating a blockade of the aminophospholipid translocase activity which is normally present in the plasma membrane of bFGF-treated cells. TPA also induced a large increase in the percentage of C6-NBD-PC and C6-NBD-PE probes which were free to diffuse laterally. The mobile fractions M reached values of approximately 100% for the two lipids, while for bFGF-treated cells they were found around 85 and 75%, respectively. For the C6-NBD-PS probe, M remained unchanged in bFGF and TPA-treated cells, at around 85%. TPA treatment also induced a twofold increase in the lateral diffusion coefficients of C6-NBD-PC and C6-NBD-PE, while that of C6-NBD-PS remained nearly unchanged. These effects of TPA may be related to the observed loss of differentiated properties of vascular endothelial cells and not to its mitogenic properties.

[1]  A. Herrmann,et al.  Transbilayer movement of fluorescent and spin-labeled phospholipids in the plasma membrane of human fibroblasts: a quantitative approach. , 1996, Journal of cell science.

[2]  J. Tocanne,et al.  Basic fibroblast growth factor modulates the aminophospholipid translocase activity present in the plasma membrane of bovine aortic endothelial cells. , 1995, European journal of biochemistry.

[3]  James M. Anderson,et al.  Assembly of the tight junction: the role of diacylglycerol , 1993, The Journal of cell biology.

[4]  J. Tocanne,et al.  Differences in the transbilayer and lateral motions of fluorescent analogs of phosphatidylcholine and phosphatidylethanolamine in the apical plasma membrane of bovine aortic endothelial cells. , 1993, Experimental cell research.

[5]  S. Citi.  Protein kinase inhibitors prevent junction dissociation induced by low extracellular calcium in MDCK epithelial cells , 1992, The Journal of cell biology.

[6]  J. Norton,et al.  Evidence for protein kinase C--independent pathways mediating phorbol ester induced plasmacytoid differentiation of B chronic lymphocytic leukemia cells. , 1991, Biochimica et biophysica acta.

[7]  J. Darbon,et al.  The respective 27 kDa and 28 kDa protein kinase C substrates in vascular endothelial and MCF-7 cells are most probably heat shock proteins. , 1990, Biochemical and biophysical research communications.

[8]  J. Tocanne,et al.  The lateral motion of lipid molecules in the apical plasma membrane of endothelial cells is reversibly affected by the presence of cell junctions. , 1989, Experimental cell research.

[9]  J. Tocanne,et al.  Effect of cell substratum on lateral mobility of lipids in the plasma membrane of vascular endothelial cells. , 1989, Experimental cell research.

[10]  A. López,et al.  Fluorescence recovery after photobleaching (FRAP) experiments under conditions of uniform disk illumination. Critical comparison of analytical solutions, and a new mathematical method for calculation of diffusion coefficient D. , 1988, Biophysical journal.

[11]  R. Pagano,et al.  Transbilayer movement of fluorescent analogs of phosphatidylserine and phosphatidylethanolamine at the plasma membrane of cultured cells. Evidence for a protein-mediated and ATP-dependent process(es). , 1987, The Journal of biological chemistry.

[12]  E. Rozengurt.  Early signals in the mitogenic response. , 1986, Science.

[13]  J. Darbon,et al.  Possible role of protein phosphorylation in the mitogenic effect of high density lipoproteins on cultured vascular endothelial cells. , 1986, The Journal of biological chemistry.

[14]  L. Cantley,et al.  Phorbol esters induce differentiation in a pre-B-lymphocyte cell line by enhancing Na+/H+ exchange. , 1984, The Journal of biological chemistry.

[15]  W. Malaisse,et al.  Binding of tumor-promoting and biologically inactive phorbol esters to artificial membranes. , 1982, Cancer letters.

[16]  G. Ojakian.  Tumor promoter-induced changes in the permeability of epithelial cell tight junctions , 1981, Cell.

[17]  J. Kremer,et al.  Vesicles of variable diameter prepared by a modified injection method. , 1977, Biochemistry.

[18]  J. Tocanne,et al.  Lateral diffusion of lipids in model and natural membranes. , 1994, Progress in lipid research.

[19]  W. Baird,et al.  Tumor promoters and the mechanism of tumor promotion. , 1980, Advances in cancer research.

[20]  D. Gospodarowicz,et al.  Structural and functional alterations in the surface of vascular endothelial cells associated with the formation of a confluent cell monolayer and with the withdrawal of fibroblast growth factor. , 1979, Journal of supramolecular structure.

[21]  P. Fisher,et al.  Action of phorbol esters in cell culture: mimicry of transformation, altered differentiation, and effects on cell membranes. , 1979, Journal of supramolecular structure.